The UK's main stock indexes were on track for a fourth straight week of losses on Friday, as investors remained on edge due to uncertainty ...

European shares surged, fueled by a ceasefire agreement between Iran and Israel brokered by U.S. President Trump, boosting investor confide...

AstraZeneca, BioNTech, GSK, Sanofi, Moderna, Novavax, Pfizer stocks today remained muted.

President Trump plans to sign an executive order mandating drugmakers to align U.S. drug prices with those of other countries, setting pric...

China-exposed luxury stocks such a LVMH and Kering shed 0.6% and 2.0%, respectively, amid continued concerns about growth in the world's se...

Soriot was tasked with turning around a troubled AstraZeneca - hit by a string of key patent losses and a spate of clinical trial failures ...

The Anglo-Swedish company's third-quarter results showed the vaccine contributed one cent to core earnings per share of $1.08, a rise of 14...

At an annual meeting of shareholders, 60.19% of votes were cast by shareholders in favour of approving Soriot's pay proposal, which takes h...

Both benchmarks touched their lowest levels since early February on Tuesday and have now fallen more than 14% from their recent highs earli...

Buying was seen across sectors, with auto and banks leading the way.

The half-dose pattern was found to be 90% effective, versus the 62% success rate of the two-full-dose main study, based on interim data.

Moderna jumped as much as 17% in New York Tuesday. The stock has surged about 73% and added more than $28 billion in market value over the ...

London and Brussels this week continue their negotiations to agree a deal on their future trading relationship, though time is now running ...

The pan-European STOXX 600 index rose 0.8%, with sub-indexes of sectors hit most by the pandemic lagging. Travel and leisure stocks fell 1....

Sensex was trading in a range with a negative bias on Monday, led by losses in Infosys, TCS, Sesa Sterlite, HDFC Bank and HUL.

Indian markets are expected to trade in a range. Here is a list of ten stocks which are likely to be in focus today.

AstraZeneca's boss said he would engage with Pfizer if the price was right and the risks posed from forcing the British drugmaker's ops int...